Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia
Top Cited Papers
Open Access
- 17 July 2013
- journal article
- research article
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 132 (5), 1086-1096.e5
- https://doi.org/10.1016/j.jaci.2013.05.020
Abstract
No abstract availableKeywords
Funding Information
- MedImmune
This publication has 27 references indexed in Scilit:
- CD203c expression on human basophils is associated with asthma exacerbationJournal of Allergy and Clinical Immunology, 2010
- Strategy Aimed at Reduction of Sputum Eosinophils Decreases Exacerbation Rate in Patients with AsthmaJournal of International Medical Research, 2006
- Determining asthma treatment by monitoring sputum cell counts: effect on exacerbationsEuropean Respiratory Journal, 2006
- Exhaled nitric oxide identifies the persistent eosinophilic phenotype in severe refractory asthmaJournal of Allergy and Clinical Immunology, 2005
- Distinguishing severe asthma phenotypes: Role of age at onset and eosinophilic inflammationJournal of Allergy and Clinical Immunology, 2004
- Repeatability of measures of inflammatory cell number in bronchial biopsies in atopic asthmaEuropean Respiratory Journal, 1997
- Identification of basophils by immunohistochemistry in the airways of post‐mortem cases of fatal asthmaClinical and Experimental Allergy, 1993
- AnaphylaxisThe New England Journal of Medicine, 1991
- Relation of perceived nasal and bronchial hyperresponsiveness to FEV1, basophil counts, and methacholine response.Thorax, 1988
- Basophils in bronchial asthma with reference to reagin‐type allergyClinical and Experimental Allergy, 1973